Get startedLog in
    Picture of Chemomab Therapeutics logo

    CMMB — Chemomab Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Chemomab Announces FDA Clearance Of Investigational New Drug Application For Phase 2 Clinical Trial Of Cm-101 In Patients With Systemic Sclerosis

    Picture of Chemomab Therapeutics logoChemomab Therapeutics
    21/02/2023 12:06
    Feb 21 (Reuters) - Chemomab Therapeutics Ltd  CMMB.O :
    * CHEMOMAB ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW
DRUG
APPLICATION FOR PHASE 2 CLINICAL TRIAL OF CM-101 IN PATIENTS
WITH SYSTEMIC SCLEROSIS

Source text for Eikon:  ID:nPny2x59a 
Further company coverage:  CMMB.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Chemomab Therapeutics

    See all news